PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 268 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 3.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,325,927 | -23.4% | 108,407 | +0.0% | 0.04% | -23.5% |
| Q2 2023 | $4,342,626 | -1.8% | 108,376 | +0.0% | 0.05% | -15.0% |
| Q1 2023 | $4,422,621 | +26.4% | 108,371 | +19.6% | 0.06% | +27.7% |
| Q4 2022 | $3,499,881 | -27.8% | 90,647 | -0.5% | 0.05% | -30.9% |
| Q3 2022 | $4,846,000 | -5.4% | 91,111 | +3.7% | 0.07% | -13.9% |
| Q2 2022 | $5,121,000 | -23.6% | 87,832 | +0.0% | 0.08% | -27.5% |
| Q1 2022 | $6,701,000 | +26.8% | 87,800 | 0.0% | 0.11% | +43.4% |
| Q4 2021 | $5,283,000 | -49.8% | 87,800 | -56.3% | 0.08% | -81.8% |
| Q2 2020 | $10,532,000 | +63.4% | 200,720 | +4.4% | 0.42% | -9.3% |
| Q1 2020 | $6,446,000 | -63.7% | 192,232 | -50.9% | 0.46% | -36.6% |
| Q4 2019 | $17,734,000 | – | 391,468 | – | 0.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |